Filling the need for trusted information on national health issues…

Public, Private Entities Continue Efforts To Develop Ebola Vaccines, Therapies

Media outlets report on various aspects of efforts to develop a vaccine for Ebola and produce more doses of experimental drugs to treat the disease.

ABC News: Will There Be an Ebola Vaccine Soon? (Besser, 10/17).
Agence France-Presse: Experimental Ebola vaccine expected in Geneva Tuesday: hospital (10/19).
Agence France-Presse: Ebola vaccine not before late 2016: GSK researcher (10/17).
The Guardian: Progress towards Ebola vaccine would have been faster had bioterrorism research been completed (Jones/Boseley, 10/17).
The Hill: Budget cuts not to blame for lack Ebola vaccine, Fauci says (Hattem, 10/19).
Reuters: GSK says Ebola vaccine development progressing at “unprecedented rate” (10/19).
Reuters: U.S. requests production plans for Ebola drug ZMapp (Begley, 10/17).
Wall Street Journal: Ebola Drug Race Ramps Up in Earnest (Loftus/McKay, 10/17).
Wall Street Journal: Why the Work of Dr. Nancy J. Sullivan Could Be Key to a Potential Ebola Vaccine (Burton, 10/19).

The Henry J. Kaiser Family Foundation Headquarters: 2400 Sand Hill Road, Menlo Park, CA 94025 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/KaiserFamFound

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in Menlo Park, California.